 SAINT LAURENT, Quebec, April 09, 2021 GLOBE NEWSWIRE -- IntelGenx Technologies Corp. TSX-V:IGX OTCQB:IGXT IntelGenx, a leader in pharmaceutical films, today announced that it is proposing to amend the terms of its 6.0 convertible unsecured promissory notes due June 1, 2021, originally issued by private placement on May 8, 2018 the Notes, to i extend the maturity date to October 31, 2024, ii change the conversion ratio for conversions at the option of the holders of the Notes from 6,250 fully paid and non-assessable shares of common stock for each U.S.5,000 aggregate principal amount of the Notes then outstanding to 11,363 fully paid and non-assessable shares of common stock for each U.S.5,000 aggregate principal amount of the Notes then outstanding, effectively representing a reduction of the conversion price from U.S.0.80 to U.S.0.44, and iii reduce the trigger price for a conversion at the option of IntelGenx from U.S.1.40 or greater for 20 consecutive trading days to U.S.0.88 or greater for 20 consecutive trading days. The proposed amendments are subject to approval of the TSX Venture Exchange and holders holding a majority of the aggregate outstanding principal amount of the Notes. 